Felimazole 1.25 mg 100 tablets

Felimazole is a veterinary drug indicated for stabilization of hyperthyroidism in cats prior to thyroidectomy and for long-term treatment of feline hyperthyroidism.

Thiamazol works in vivo by blocking thyroid hormone biosynthesis. Its main action is to inhibit the binding of iodate to the thyroid peroxidase enzyme, preventing the catalyzed iodination of thyroglobulin and the synthesis of T3 and T4.

Dosage and administration route:

For oral administration only.

For stabilization of feline hyperthyroidism prior to surgical thyroidectomy and for long-term treatment of feline hyperthyroidism, the recommended starting dose is 5 mg per day.

Whenever possible, the total daily dose should be divided into two and administered in the morning and in the evening. Tablets must not be split in half.

If, for compliance reasons, once daily dosing with one 5 mg tablet is preferable, it is acceptable that 2.5 mg of the tablet be administered twice daily to be more effective in the short term. The 5mg tablet is also suitable for cats who need a higher dose.

Hematology, biochemistry, and serum total T4 should be assessed before starting treatment and after 3 weeks, 6 weeks, 10 weeks, 20 weeks, and quarterly thereafter.

At each of the recommended monitoring intervals, the dose should be titrated to take effect according to the total T4 and clinical response to treatment. Dose adjustments should be made in 2.5 mg increments and the goal should be to achieve the lowest possible dose frequency.

If a dose greater than 10 mg per day is required, animals should be closely monitored.

The dose administered should not exceed 20 mg/day.

For the long-term treatment of hyperthyroidism, the animal must be treated for life.

As it is a veterinary drug subject to a medical prescription , we request that it be sent to the email: [email protected]